4 research outputs found
Near-Infrared Light-Excited Upconverting Persistent Nanophosphors in Vivo for Imaging-Guided Cell Therapy
Optical
imaging for biological applications is in need of more
sensitive tool. Persistent luminescent nanophosphors enable highly
sensitive in vivo optical detection and almost completely avoid tissue
autofluorescence. Nevertheless, the actual persistent luminescent
nanophosphors necessitate ex vivo activation before systemic operation,
which severely restricted the use of long-term imaging in vivo. Hence,
we introduced a novel generation of optical nanophosphors, based on
(Zn<sub>2</sub>SiO<sub>4</sub>:Mn):Y<sup>3+</sup>, Yb<sup>3+</sup>, Tm<sup>3+</sup> upconverting persistent luminescent nanophosphors;
these nanophosphors can be excited in vivo through living tissues
by highly penetrating near-infrared light. We can trace labeled tumor
therapeutic macrophages in vivo after endocytosing these nanophosphors
in vitro and follow macrophages biodistribution by a simple whole
animal optical detection. These nanophosphors will open novel potentials
for cell therapy research and for a variety of applications in diagnosis
in vivo
Near-Infrared Light Triggered Upconversion Optogenetic Nanosystem for Cancer Therapy
<i>In vivo</i> the application of optogenetic manipulation
in deep tissue is seriously obstructed by the limited penetration
depth of visible light that is continually applied to activate a photoactuator.
Herein, we designed a versatile upconversion optogenetic nanosystem
based on a blue-light-mediated heterodimerization module and rare-earth
upconversion nanoparticles (UCNs). The UCNs worked as a nanotransducer
to convert external deep-tissue-penetrating near-infrared (NIR) light
to local blue light to noninvasively activate photoreceptors for optogenetic
manipulation <i>in vivo</i>. In this, we demonstrated that
deeply penetrating NIR light could be used to control the apoptotic
signaling pathway of cancer cells in both mammalian cells and mice
by UCNs. We believe that this interesting NIR-light-responsive upconversion
optogenetic nanotechnology has significant application potentials
for both basic research and clinical applications <i>in vivo</i>